What is Certus Laboratories?
Certus Laboratories operates as an independent diagnostic facility, providing essential toxicology and COVID-19 testing services. By integrating advanced laboratory technology with a client-centric service philosophy, the firm bridges the gap between complex diagnostic requirements and the immediate needs of healthcare providers. Their market position is defined by a commitment to high-quality results and streamlined supply chain management, ensuring that medical professionals receive actionable data with minimal latency. This operational focus has allowed Certus Laboratories to become a vital partner for regional healthcare systems, facilitating better patient outcomes through reliable and efficient diagnostic reporting.
How much funding has Certus Laboratories raised?
Certus Laboratories has raised a total of $428K across 2 funding rounds:
Debt
$150K
Debt
$278K
Debt (2020): $150K with participation from PPP
Debt (2021): $278K led by PPP
Key Investors in Certus Laboratories
PPP
Public-Private Partnership
What's next for Certus Laboratories?
With the successful completion of its recent financing, Certus Laboratories is well-positioned to optimize its laboratory infrastructure and further refine its diagnostic throughput. The strategic deployment of this capital will likely focus on enhancing technological integration and expanding service capacity to accommodate a broader range of clinical testing requirements. As the firm transitions into this next phase of growth, the emphasis will remain on maintaining the high standards of accuracy and service that have defined its market presence. Future initiatives may include the adoption of next-generation testing platforms and the expansion of its logistics network to further improve the speed and accessibility of its diagnostic offerings for healthcare providers across the region.
See full Certus Laboratories company page